In a decision that shocked some observers, key advisers to the US Food and Drug Administration (FDA) voted that the effectiveness of the party drug MDMA for treating post-traumatic stress disorder is ...
Rick Doblin spent more than 30 years trying to turn the psychedelic drug MDMA into an accepted medical treatment for post-traumatic stress disorder. Earlier this month, the Food and Drug ...
A corporation dedicated to studying the benefits of psychedelic drugs filed an application with the Food and Drug Administration this week for approval to use MDMA—aka ecstasy or molly—in combination ...
The path toward federal approval for medical treatments involving psychedelics may be longer and less straightforward after the US Food and Drug Administration denied the first application for a ...
Forbes contributors publish independent expert analyses and insights. I write about cannabis and psychedelics culture and business. PTSD is a serious medical condition that affects 13 million ...
This story has been updated to correct the misspelling of Lykos Therapeutics. We regret the error. These drugs, often praised for their potential benefits, can cause ...
NSW Health has issued an urgent public warning after multiple high-dose MDMA (ecstasy) tablets were detected circulating at a ...
A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should ...
Today, the FDA issued a complete response letter (CRL) for midomafetamine capsules (MDMA) in combination with assisted therapy (MDMA-AT) for adults living with posttraumatic stress disorder (PTSD).
As anyone who has been to Shakedown Street knows, the drug cocktail of LSD and MDMA is referred to as “candyflipping.” But for JR Rahn, the founder and co-CEO of psychedelic drug development startup ...
A wave of high-strength MDMA pills branded with pop-culture logos and luxury labels are circulating across New South Wales, ...
VANCOUVER, British Columbia, May 14, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada-licensed GMP psychedelics pharmaceutical manufacturer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results